Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy
about
Ocular Complications of Diabetes and Therapeutic ApproachesAssociation between aqueous humor and vitreous fluid levels of Th17 cell-related cytokines in patients with proliferative diabetic retinopathy.Scutellaria barbata attenuates diabetic retinopathy by preventing retinal inflammation and the decreased expression of tight junction protein.Serum and vitreous levels of visfatin in patients with diabetic retinopathyDendrobium chrysotoxum Lindl. alleviates diabetic retinopathy by preventing retinal inflammation and tight junction protein decreaseRegulated in development and DNA damage 1 is necessary for hyperglycemia-induced vascular endothelial growth factor expression in the retina of diabetic rodentsElevated Levels of Cytokines Associated with Th2 and Th17 Cells in Vitreous Fluid of Proliferative Diabetic Retinopathy Patients.Elevated Serum Levels of Soluble TNF Receptors and Adhesion Molecules Are Associated with Diabetic Retinopathy in Patients with Type-1 Diabetes.Intra-silicone oil injection of methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy.RNA sequencing reveals retinal transcriptome changes in STZ-induced diabetic rats.Inflammatory cytokine-specific alterations in retinal endothelial cell function.The significance of the increased expression of phosphorylated MeCP2 in the membranes from patients with proliferative diabetic retinopathy.Inflammation and pharmacological treatment in diabetic retinopathy.From pathobiology to the targeting of pericytes for the treatment of diabetic retinopathyInflammatory markers and cardiometabolic diseases.Diabetic Retinopathy: Vascular and Inflammatory Disease.Endothelial STAT3 Activation Increases Vascular Leakage Through Downregulating Tight Junction Proteins: Implications for Diabetic Retinopathy.Negative regulators of angiogenesis: important targets for treatment of exudative AMD.Severe prelenticular membrane formation on the surface of a hydrophilic acrylic intraocular lens after cataract surgery in an eye with an Ahmed valve implant.Retinal microangiopathy in a mouse model of inducible mural cell loss.Angiogenic Factors and Cytokines in Diabetic Retinopathy.Angiogenin gene polymorphism: A risk factor for diabetic peripheral neuropathy in the northern Chinese Han population.Angiogenesis and Inflammation Crosstalk in Diabetic Retinopathy.The impact of ranibizumab on the level of intercellular adhesion molecule type 1 in the vitreous of eyes with proliferative diabetic retinopathy.Levels of Inflammatory Cytokines IL-1β, IL-6, IL-8, IL-17A, and TNF-α in Aqueous Humour of Patients with Diabetic Retinopathy.The effects of alpha-lipoic acid supplementation on inflammatory markers among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials.
P2860
Q26749412-0AC64725-4668-4F33-AC1F-6E6E67974040Q33739264-3F498EBB-7CA8-4F91-9842-31DF7AFE0C2EQ33914624-F1E53DC3-877B-46DD-917D-4C6B8AE934A0Q34789505-54515975-5DFE-46FB-9E43-5570C008C5A8Q35035441-376F9C25-18B4-4DF6-861E-1E783056438FQ35055667-6FDF7803-61CD-4D3C-9A52-498943AC9163Q35768068-7C70417D-3903-4C57-9FB1-74F8D343E2D4Q35962884-1D07B7EA-E6EA-49C2-906A-1E898A27E362Q36048817-A45F77AC-F7A7-44D4-A5E2-208767922783Q36624029-F6BC2517-6458-453A-AA9D-21693CFF0B00Q37150614-C9AD819D-C683-406B-8933-1459DF35884FQ37247435-2B77A033-B882-4172-957B-3542B02FB7D5Q38167309-C8059AD2-1B2D-4C8D-B4F0-773F1ECE74CAQ38332124-7F0F31D5-299C-4470-8410-C28060199062Q38535519-22240A27-C283-45D8-858E-2064B45E7999Q38542115-0772BE40-C261-4B74-98A8-3929008F89E5Q38748869-7FFCB54B-7865-40C0-BD44-A999345C8839Q39416208-725F5C38-CD74-4DBD-968B-DEE8A1EF63D5Q40050505-7E4E48BC-3B05-4961-956B-65BFFC289CCCQ41816335-CA3E5F07-C6C9-4AD8-B2FD-4C0ECB5DC6A4Q41883466-287A1C98-D26A-449C-AF2E-B24F38DFA1BDQ42084622-98499050-91DE-4F6E-B22C-78CEF19FB85BQ53111788-4A36E926-0BCC-4F7E-93DA-1F6BF17FDBDBQ53380645-1776C01C-E2F8-4D1D-85B3-86CF978AC0A7Q55003873-65CDA942-F337-489B-9462-EFA715405CB7Q55183262-77DA6F6D-18CD-4A42-9774-575AB1A931E5
P2860
Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Therapeutic interventions agai ...... iferative diabetic retinopathy
@ast
Therapeutic interventions agai ...... iferative diabetic retinopathy
@en
Therapeutic interventions agai ...... iferative diabetic retinopathy
@nl
type
label
Therapeutic interventions agai ...... iferative diabetic retinopathy
@ast
Therapeutic interventions agai ...... iferative diabetic retinopathy
@en
Therapeutic interventions agai ...... iferative diabetic retinopathy
@nl
prefLabel
Therapeutic interventions agai ...... iferative diabetic retinopathy
@ast
Therapeutic interventions agai ...... iferative diabetic retinopathy
@en
Therapeutic interventions agai ...... iferative diabetic retinopathy
@nl
P2860
P921
P3181
P356
P1476
Therapeutic interventions agai ...... iferative diabetic retinopathy
@en
P2093
Aristomenis Thanos
Daniel Gologorsky
P2860
P304
P3181
P356
10.1155/2012/629452
P407
P5008
P577
2012-09-17T00:00:00Z